ScreenIn3D (S3D) is dedicated to revolutionizing drug discovery through patented lab-on-a-chip technology that provides higher throughput investigation of candidate molecules on translational live tissue samples and complex 3D models of biology, such as 3D multicellular tumors and organoids, thus reducing the uncertainty associated with existing preclinical models.
Extensive validation shows that micro sizing drug-cell interactions reduces cost of experiments significantly as well as increasing productivity as it enables more experiments to be done on the same platform at the same time.
The microfluidic platform delivers precise control over the cellular microenvironment and beneficially through miniaturization, maximizes use of precious limited human cancer samples, enabling long-term culture for drug screening and individualized therapeutic multi-modality testing. Developed using leading-edge microsystem engineering, the platform delivers high-throughput analysis and is fully compatible with robotic dispensing and high content imaging systems.
